March 31 (Reuters) - CRISPR Therapeutics AG:
* CRISPR THERAPEUTICS AG - SUPPLEMENTING RISK FACTORS ON FORM 10-K WITH POTENTIAL IMPACTS FROM CORONAVIRUS PANDEMIC - SEC FILING Source text: bit.ly/3bHHC8s Further company coverage:
Our Standards:The Thomson Reuters Trust Principles.
![Understanding the diversity of genetic outcomes from CRISPR-Cas […]](https://www.breathinglabs.com/wp-content/themes/hathor-pro/images/thumb-medium.png)
